U.S. authorizes J&J's COVID-19 vaccine, making it third available


  • World
  • Sunday, 28 Feb 2021

Vials of Johnson & Johnson's Janssen coronavirus disease (COVID-19) vaccine candidate are seen in an undated photograph. Johnson & Johnson/Handout via REUTERS.

(Reuters) - The U.S. government on Saturday authorized Johnson & Johnson's single-dose COVID-19 vaccine, enabling millions more Americans to be vaccinated in the coming weeks and setting the vaccine up for additional approvals around the world.

The J&J vaccine is the third authorized in the United States, following ones from Pfizer/BioNTech and Moderna, both of which require two doses.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

North Korea's Kim accuses US of stoking tension, warns of nuclear war, KCNA says
Canada to give holiday tax break for groceries
U.S. stocks close higher
Slovak PM shooting suspect faces prolonged custody
Gas Leak prompts evacuation of 150 people in Prague
Nations strive for climate funding consensus as COP29 deadline nears
Biden's shift on missiles for Ukraine informed by North Korean troops in Kursk, Trump's election victory
Wall Street top regulator to leave SEC when Trump takes office
U.S. automakers plan to acquire Trump's nod to sell EVs: NYT
Crude futures settle higher

Others Also Read